Completed the consolidation of Shinwa Seimitsu Co., Ltd. and three other subsidiaries. Due to changes in equity-method affiliates, RYS and STP are also scheduled to become consolidated subsidiaries. The transfer agreement date and execution date were延期・変更, and the share transfer was completed on June 15, 2026. The impact on the fiscal year ending March 2027 from the first quarter onward...
Total dividends received from consolidated subsidiaries amounting to 3,660 million yen are recorded as non-operating income for the fiscal year ending March 2026. There is no direct impact on consolidated performance; careful monitoring of future performance is necessary.
As of November 4, 2025, the trade names of consolidated subsidiary Mitsui Kinzoku Act Corporation and its subsidiary were changed to Hirlex Act Corporation and Haidesi Akute (Shanghai) Enterprise Management Co., Ltd., respectively.
On May 1, 2026, an absorption-type company split and absorption-type merger will be conducted between consolidated subsidiaries to mutually succeed part of the pharmacy business, and Sakura Pharmacy Co., Ltd. will be absorbed by Kraft Co., Ltd.